ATS
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to Personal Folders
Right arrow Download to citation manager
Right arrow Author home page(s):
Christos Alexiou
Edward Black
Mark L. Field
John P. Duffy
David F. Beggs
Right arrow Permission Requests
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Alexiou, C.
Right arrow Articles by Beggs, D. F.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Alexiou, C.
Right arrow Articles by Beggs, D. F.
Related Collections
Right arrow Esophagus - cancer

Ann Thorac Surg 2006;82:1073-1077
© 2006 The Society of Thoracic Surgeons


Original article: General thoracic

Survival After Esophageal Resection for Carcinoma: The Importance of the Histologic Cell Type

Christos Alexiou, FRCS, PhD, Omar A. Khan, MRCS, Edward Black, FRCS(CTh), Mark L. Field, MRCS, PhD, Patrick Onyeaka, FRCS, Lynda Beggs, RGN, John P. Duffy, FRCS, MS, David F. Beggs, FRCS, FECTS*

Department of Cardiothoracic Surgery, Nottingham City Hospital, Nottingham, United Kingdom

Accepted for publication March 7, 2006.

* Address correspondence to Dr Beggs, Thoracic Unit, Nottingham City Hospital, Hucknall Road, Nottingham, NG5 1PB, United Kingdom (Email: dbeggs{at}ncht.trent.nhs.uk).

BACKGROUND: The significance of tumor cell type on survival after esophageal resection for carcinoma is uncertain. We reviewed our experience in order to compare the outcome in the two main histologic groups.

METHODS: Between January 1987 and April 2000, 621 patients underwent esophagectomy with curative intention for squamous cell carcinoma or adenocarcinoma. The postoperative outcomes of patients with adenocarcinoma and squamous cell carcinoma were compared.

RESULTS: Of the cohort, 424 patients had adenocarcinoma (group A) and 197 had squamous cell carcinoma (group B). The commonest approach in group A was a left thoracotomy (67%), while in group B, it was an Ivor Lewis resection (55%) (p < 0.0001). Operative mortality was 3.5% for group A and 8.1% for group B (p = 0.03). Cardiorespiratory complication rate was similar, but anastomotic leaks occurred more frequently in group B (4.2% vs 8.6%, p = 0.04). Patients in group B tended to have earlier pathologic tumor, node, metastasis (pTNM) stage (p = 0.06). Overall, survival was significantly better for group B (p = 0.003). Group B had a significantly better survival than group A in lymph node (LN) negative status (p = 0.01), and a relatively improved survival in LN positive status (p = 0.35). On multivariate analysis, squamous cell subtype (p = 0.034), pTNM stage (p = 0.005), LN status (p = 0.008), and completeness of resection (p = 0.028) were significant predictors of survival.

CONCLUSIONS: After esophagectomy, patients with squamous cell carcinoma have a poorer perioperative outcome as compared with those with adenocarcinoma. However, in the longer term, squamous cell type appears to confer a significant survival advantage.




This article has been cited by other articles:


Home page
Ann. Thorac. Surg.Home page
P. C. Lee, J. L. Port, S. Paul, B. M. Stiles, and N. K. Altorki
Predictors of long-term survival after resection of esophageal carcinoma with nonregional nodal metastases.
Ann. Thorac. Surg., July 1, 2009; 88(1): 186 - 193.
[Abstract] [Full Text] [PDF]


Home page
J. Thorac. Cardiovasc. Surg.Home page
N. Safieddine, W. Xu, S. M. Quadri, J. J. Knox, J. Hornby, J. Sulman, R. Wong, M. Guindi, S. Keshavjee, and G. Darling
Health-related quality of life in esophageal cancer: effect of neoadjuvant chemoradiotherapy followed by surgical intervention.
J. Thorac. Cardiovasc. Surg., January 1, 2009; 137(1): 36 - 42.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Pathol.Home page
J Boone, F J W T. Kate, G J A Offerhaus, P J van Diest, I H M B. Rinkes, and R van Hillegersberg
mTOR in squamous cell carcinoma of the oesophagus: a potential target for molecular therapy?
J. Clin. Pathol., August 1, 2008; 61(8): 909 - 913.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
ANN THORAC SURG ASIAN CARDIOVASC THORAC ANN EUR J CARDIOTHORAC SURG
J THORAC CARDIOVASC SURG ICVTS ALL CTSNet JOURNALS
Copyright © 2006 by The Society of Thoracic Surgeons.